MUNICH--(BUSINESS WIRE)--BioVaria is designed for dealmakers and investors from the global life-science sector responsible for identifying, licensing or funding break-through innovations. In just one interactive day, it showcases around 50 licensable life-science technologies and spin-offs originating from publicly funded research. // BioVaria presents cutting-edge IP assets and spin-offs originating from Europe’s leading life-science institutions. It is a unique opportunity to discover high-po
| < Prev | Next > |
|---|
